← Leaderboards
Nadia N Hansel
Johns Hopkins University
$30,283,781
Attributed
$36,722,432
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,087,802 · 18
By mechanism
R01$17,549,700 · 5
P50$10,257,715 · 5
U01$5,833,457 · 1
T32$3,843,421 · 1
UH3$3,465,062 · 1
UG3$1,826,564 · 1
Top collaborators
- Joel Daniel Kaufman5 shared
- Nirupama Putcha3 shared
- Larissa A Shimoda3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nirupama Putcha$7,704,235
- Meredith C McCormack$14,784,022
- Gregory B Diette$8,022,684
- Craig Evan Pollack$11,756,652
- Corinne Keet$22,056,351
Others in their field
Top investigators on “Morbidity - Disease Rate”
- Marco Pahor · Wake Forest University Health Sciences$29,421,775
- A Benedict Cosimi · Massachusetts General Hospital$17,236,164
- Judith S. Currier · University Of California Los Angeles$11,229,603
- Andrea Jenay Ruff · Johns Hopkins University$10,896,035
- Lucile L Adams-Campbell · Howard University$10,384,616
- Michael K Ong · University Of California Los Angeles$9,898,332
Research focus
Morbidity - Disease RatePollutantParticulate MatterResearch PersonnelCause Of DeathAffectCommunitiesEpidemiologyUnited StatesRespiratoryExposure ToChronic Obstructive Airway DiseaseNitrogen DioxideQuality Of LifeSymptomsPredispositionIndoor Air PollutionFundingAir PollutionEnvironmentAreaProgramsAir PollutantsPrevalence
Grant awards (70)
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD$2,771,146
U01 · FY2025 · AI
1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD$1,707,493
UH3 · FY2025 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,429,964
T32 · FY2025 · HL
OMEGA COPD Trial$748,362
R01 · FY2025 · HL · contact PI
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD$541,808
U01 · FY2025 · AI
Development Core$301,002
P2C · FY2025 · ES · contact PI
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD$2,520,503
U01 · FY2024 · AI
1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD$1,757,569
UH3 · FY2024 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,026,463
T32 · FY2024 · HL
OMEGA COPD Trial$762,924
R01 · FY2024 · HL · contact PI
Development Core$276,459
P2C · FY2024 · ES · contact PI
1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD$1,826,564
UG3 · FY2023 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,386,994
T32 · FY2023 · HL
OMEGA COPD Trial$789,956
R01 · FY2023 · HL · contact PI
Development Core$239,411
P2C · FY2023 · ES · contact PI
OMEGA COPD Trial$810,698
R01 · FY2022 · HL · contact PI
Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD)$627,293
R01 · FY2022 · ES · contact PI
Development Core$239,411
P2C · FY2022 · ES · contact PI
OMEGA COPD Trial$818,003
R01 · FY2021 · HL · contact PI
Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD)$642,562
R01 · FY2021 · ES · contact PI
Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD)$658,052
R01 · FY2020 · ES · contact PI
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)$730,000
P50 · FY2019 · MD · contact PI
Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD)$671,770
R01 · FY2019 · ES · contact PI
Project 1: Obesity and adverse dietary patterns as susceptibility factors to pollutant exposure in urban COPD.$208,683
P50 · FY2019 · MD · contact PI
The Administrative Core$71,980
P50 · FY2019 · MD · contact PI
Obesity Enhances Susceptibility to Pollutant Effects in Asthma$35,370
P50 · FY2019 · ES · contact PI
Obesity Enhances Susceptibility to Pollutant Effects in Asthma$1,200,000
P50 · FY2018 · ES · contact PI
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)$700,000
P50 · FY2018 · MD · contact PI
Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD)$688,706
R01 · FY2018 · ES · contact PI
SPIROMICS - Air Pollution Study$608,225
R01 · FY2018 · ES · contact PI
Project 1: Obesity and adverse dietary patterns as susceptibility factors to pollutant exposure in urban COPD.$199,901
P50 · FY2018 · MD · contact PI
Adminstrative Core$161,768
P50 · FY2018 · ES · contact PI
The Administrative Core$69,597
P50 · FY2018 · MD · contact PI
Obesity Enhances Susceptibility to Pollutant Effects in Asthma$1,200,000
P50 · FY2017 · ES · contact PI
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)$700,000
P50 · FY2017 · MD · contact PI
Clinical trial of air cleaners to improve indoor air quality and COPD health$658,491
R01 · FY2017 · ES · contact PI
SPIROMICS - Air Pollution Study$634,129
R01 · FY2017 · ES · contact PI
Project 1: Obesity and adverse dietary patterns as susceptibility factors to pollutant exposure in urban COPD.$199,863
P50 · FY2017 · MD · contact PI
Adminstrative Core$154,519
P50 · FY2017 · ES · contact PI
The Administrative Core$69,708
P50 · FY2017 · MD · contact PI
Obesity Enhances Susceptibility to Pollutant Effects in Asthma$1,200,000
P50 · FY2016 · ES · contact PI
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)$700,000
P50 · FY2016 · MD · contact PI
Clinical trial of air cleaners to improve indoor air quality and COPD health$661,245
R01 · FY2016 · ES · contact PI
SPIROMICS - Air Pollution Study$615,011
R01 · FY2016 · ES · contact PI
Adminstrative Core$148,713
P50 · FY2016 · ES · contact PI
The Administrative Core$116,668
P50 · FY2016 · MD · contact PI
Project 1: Obesity and adverse dietary patterns as susceptibility factors to pollutant exposure in urban COPD.$116,668
P50 · FY2016 · MD · contact PI
Obesity Enhances Susceptibility to Pollutant Effects in Asthma$1,200,000
P50 · FY2015 · ES · contact PI
Comparing Urban and Rural Effects of Poverty on COPD (CURE COPD)$700,000
P50 · FY2015 · MD · contact PI
Clinical trial of air cleaners to improve indoor air quality and COPD health$673,901
R01 · FY2015 · ES · contact PI
SPIROMICS - Air Pollution Study$649,030
R01 · FY2015 · ES · contact PI
Project 1: Obesity and adverse dietary patterns as susceptibility factors to pollutant exposure in urban COPD.$148,353
P50 · FY2015 · MD · contact PI
Adminstrative Core$146,791
P50 · FY2015 · ES · contact PI
The Administrative Core$79,133
P50 · FY2015 · MD · contact PI
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru$988,001
R01 · FY2014 · ES · contact PI
SPIROMICS - Air Pollution Study$694,029
R01 · FY2014 · ES · contact PI
Clinical trial of air cleaners to improve indoor air quality and COPD health$673,185
R01 · FY2014 · ES · contact PI
Clinical trial of air cleaners to improve indoor air quality and COPD health$688,419
R01 · FY2013 · ES · contact PI
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru$572,834
R01 · FY2013 · ES · contact PI
Genetic Susceptibility to Asthma and Indoor Air Pollution in Peru$410,571
R01 · FY2013 · ES · contact PI
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru$603,335
R01 · FY2012 · ES · contact PI
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru$605,967
R01 · FY2011 · ES · contact PI
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru$595,001
R01 · FY2010 · ES · contact PI
Domestic endotoxin exposure and chronic obstructive pulmonary disease$205,000
R21 · FY2009 · ES · contact PI
Domestic endotoxin exposure and chronic obstructive pulmonary disease$246,000
R21 · FY2008 · ES · contact PI
Genetics of Asthma Severity and Lung Function Decline$160,920
K23 · FY2008 · HL · contact PI
Genetics of Asthma Severity and Lung Function Decline$160,920
K23 · FY2007 · HL · contact PI
Genetics of Asthma Severity and Lung Function Decline$160,920
K23 · FY2006 · HL · contact PI
Genetics of Asthma Severity and Lung Function Decline$160,920
K23 · FY2005 · HL
Genetics of Asthma Severity and Lung Function Decline$160,920
K23 · FY2004 · HL